those with severe renal impairment. We found no justification in the literature for higher doses.
. Figure 4 presents the time-series data for metronidazole dosages. Because of less frequent use of this antibiotic, metronidazole data were aggregated over 12-week rather than four-week periods to increase stability of the time series. Excessive (every six hours) metronidazole therapy schedules also dropped precipitously from 75% of patientdays in the preintervention period to approximately 6% after the start of the intervention (P<.01). The tions. However, it is our position that the ultimate discre¬ tion must remain in the hands of the ordering physician, who after all maintains final responsibility for the welfare of the patient.
